Cargando…
Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans Simultaneously by MALDI-MS
[Image: see text] Differences in ionization efficiency among neutral and sialylated glycans prevent direct quantitative comparison by their respective mass spectrometric signals. To overcome this challenge, we developed an integrated chemical strategy, Dual Reactions for Analytical Glycomics (DRAG),...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082391/ https://www.ncbi.nlm.nih.gov/pubmed/24766348 http://dx.doi.org/10.1021/ac500298a |
_version_ | 1782324251001356288 |
---|---|
author | Zhou, Hui Warren, Peter G. Froehlich, John W. Lee, Richard S. |
author_facet | Zhou, Hui Warren, Peter G. Froehlich, John W. Lee, Richard S. |
author_sort | Zhou, Hui |
collection | PubMed |
description | [Image: see text] Differences in ionization efficiency among neutral and sialylated glycans prevent direct quantitative comparison by their respective mass spectrometric signals. To overcome this challenge, we developed an integrated chemical strategy, Dual Reactions for Analytical Glycomics (DRAG), to quantitatively compare neutral and sialylated glycans simultaneously by MALDI-MS. Initially, two glycan samples to be compared undergo reductive amination with 2-aminobenzoic acid and 2-(13)[C(6)]-aminobenzoic acid, respectively. The different isotope-incorporated glycans are then combined and subjected to the methylamidation of the sialic acid residues in one mixture, homogenizing the ionization responses for all neutral and sialylated glycans. By this approach, the expression change of relevant glycans between two samples is proportional to the ratios of doublet signals with a static 6 Da mass difference in MALDI-MS and the change in relative abundance of any glycan within samples can also be determined. The strategy was chemically validated using well-characterized N-glycans from bovine fetuin and IgG from human serum. By comparing the N-glycomes from a first morning (AM) versus an afternoon (PM) urine sample obtained from a single donor, we further demonstrated the ability of DRAG strategy to measure subtle quantitative differences in numerous urinary N-glycans. |
format | Online Article Text |
id | pubmed-4082391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | American
Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-40823912015-04-25 Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans Simultaneously by MALDI-MS Zhou, Hui Warren, Peter G. Froehlich, John W. Lee, Richard S. Anal Chem [Image: see text] Differences in ionization efficiency among neutral and sialylated glycans prevent direct quantitative comparison by their respective mass spectrometric signals. To overcome this challenge, we developed an integrated chemical strategy, Dual Reactions for Analytical Glycomics (DRAG), to quantitatively compare neutral and sialylated glycans simultaneously by MALDI-MS. Initially, two glycan samples to be compared undergo reductive amination with 2-aminobenzoic acid and 2-(13)[C(6)]-aminobenzoic acid, respectively. The different isotope-incorporated glycans are then combined and subjected to the methylamidation of the sialic acid residues in one mixture, homogenizing the ionization responses for all neutral and sialylated glycans. By this approach, the expression change of relevant glycans between two samples is proportional to the ratios of doublet signals with a static 6 Da mass difference in MALDI-MS and the change in relative abundance of any glycan within samples can also be determined. The strategy was chemically validated using well-characterized N-glycans from bovine fetuin and IgG from human serum. By comparing the N-glycomes from a first morning (AM) versus an afternoon (PM) urine sample obtained from a single donor, we further demonstrated the ability of DRAG strategy to measure subtle quantitative differences in numerous urinary N-glycans. American Chemical Society 2014-04-25 2014-07-01 /pmc/articles/PMC4082391/ /pubmed/24766348 http://dx.doi.org/10.1021/ac500298a Text en Copyright © 2014 American Chemical Society Terms of Use (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) |
spellingShingle | Zhou, Hui Warren, Peter G. Froehlich, John W. Lee, Richard S. Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans Simultaneously by MALDI-MS |
title | Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans
Simultaneously by MALDI-MS |
title_full | Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans
Simultaneously by MALDI-MS |
title_fullStr | Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans
Simultaneously by MALDI-MS |
title_full_unstemmed | Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans
Simultaneously by MALDI-MS |
title_short | Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans
Simultaneously by MALDI-MS |
title_sort | dual modifications strategy to quantify neutral and sialylated n-glycans
simultaneously by maldi-ms |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082391/ https://www.ncbi.nlm.nih.gov/pubmed/24766348 http://dx.doi.org/10.1021/ac500298a |
work_keys_str_mv | AT zhouhui dualmodificationsstrategytoquantifyneutralandsialylatednglycanssimultaneouslybymaldims AT warrenpeterg dualmodificationsstrategytoquantifyneutralandsialylatednglycanssimultaneouslybymaldims AT froehlichjohnw dualmodificationsstrategytoquantifyneutralandsialylatednglycanssimultaneouslybymaldims AT leerichards dualmodificationsstrategytoquantifyneutralandsialylatednglycanssimultaneouslybymaldims |